Page 92 - ARNM-2-4

Advances in Radiotherapy
& Nuclear Medicine Dose prescription and reporting in SRS

D , conformity, homogeneity indexes, and dose-metrics References
99
dependencies on the treatment site and RMP approach. Due 1. Das IJ, Yadav P, Andersen AD, et al. Dose prescription
to the unification applied in our hospital during the last years, and reporting in stereotactic body radiotherapy: A multi-
the data demonstrated relatively low variability despite having institutional study. Radiother Oncol. 2023;182:109571.
some site- and planner-specific features. Our standardization
advanced through the continuous implementation of auto- doi: 10.1016/j.radonc.2023.109571
contouring programs, treatment planning systems, and QA 2. Schiff PB. Dose dissonance in radiation oncology: Consensus
automation software, which allow the creation of templates needed when prescribing dose in radiation therapy. Pract
for each step of the radiation treatment workflow. For Radiat Oncol. 2017;7(6):e579-e580.
example, organ nomenclature and dose-volume metrics can doi: 10.1016/j.prro.2017.04.018
be easily pre-defined for planning and reporting.
3. Moustakis C, Blanck O, Ebrahimi F, et al. Time for
Further multi-institutional comparisons and the standardization of SBRT planning through large scale
adoption of standardized SBRT practices across countries clinical data and guideline-based approaches. Zeit für
and institutions could significantly accelerate the eine Standardisierung der SBRT-Planung mithilfe großer
availability of coherent clinical data, thereby enhancing klinischer Datenmengen und leitlinienbasierter Ansätze.
Strahlenther Onkol. 2017;193(12):1068-1069.
both the quality and efficiency of radiation therapy globally.
doi: 10.1007/s00066-017-1216-8
Acknowledgments 4. Moustakis C, Blanck O, Ebrahimi Tazehmahalleh F, et al.

None. Planning benchmark study for SBRT of early stage NSCLC:
Results of the DEGRO Working Group Stereotactic
Funding Radiotherapy. Planvergleichsstudie bei der SBRT des NSCLC
im Frühstadium: Ergebnisse der DEGRO AG Stereotaxie.
None. Strahlenther Onkol. 2017;193(10):780-790.
Conflict of interest doi: 10.1007/s00066-017-1151-8
The authors declare they have no competing interests. 5. Eaton DJ, Naismith OF, Henry AM. Need for consensus
when prescribing stereotactic body radiation therapy for
Author contributions prostate cancer. Int J Radiat Oncol Biol Phys. 2015;91(1)
:239-241.
Conceptualization: Salem Billan, Egor Borzov doi: 10.1016/j.ijrobp.2014.09.025
Formal analysis: Egor Borzov
Investigation: Egor Borzov 6. ICRU Report 91: Prescribing, Recording, and reporting of
Methodology: Egor Borzov Stereotactic Treatments with Small Photon Beams; 2017.
Writing–original draft: Egor Borzov 7. Guckenberger M, Andratschke N, Dieckmann K, et al.
Writing–review & editing: Tomer Charas, Raquel Bar- ESTRO ACROP consensus guideline on implementation and
Deroma practice of stereotactic body radiotherapy for peripherally
located early stage non-small cell lung cancer. Radiother
Ethics approval and consent to participate Oncol. 2017;124(1):11-17.
This research was approved by IRB as a retrospective data doi: 10.1016/j.radonc.2017.05.012
analysis trial. The trial number is 0222-23-RMB-D. 8. Moustakis C, Blanck O, Chan MKH, et al. Planning
benchmark study for stereotactic body radiation therapy
Consent for publication of liver metastases: Results of the DEGRO/DGMP working
Not applicable. group on stereotactic radiation therapy and radiosurgery.
Int J Radiat Oncol Biol Phys. 2022;113(1):214-227.
Availability of data doi: 10.1016/j.ijrobp.2022.01.008

Data are available from the corresponding author upon 9. ICRU Report 83: Prescribing, Recording, and Reporting
reasonable request. Photon-Beam Intensity-Modulated Radiation Therapy
(IMRT); 2010.
Further disclosure 10. Patel G, Mandal A, Choudhary S, Mishra R, Shende R. Plan
Part of this study was presented as a Digital Poster in the evaluation indices: A journey of evolution. Rep Pract Oncol
FARO-ESTRO Congress @ ESTRO meets Asia 2024, Kuala Radiother. 2020;25(3):336-344.
Lumpur, Malaysia, August 23 – 25, 2024. doi: 10.1016/j.rpor.2020.03.002

Volume 2 Issue 4 (2024) 5 doi: 10.36922/arnm.5450